ConductScience.org, home

Gene · 2592

GALT: galactose-1-phosphate uridylyltransferase

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. GALT: galactose-1-phosphate uridylyltransferase. Genes, record 2592. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2592

On this page

Gene

Symbol
GALT
HGNC
Name
galactose-1-phosphate uridylyltransferase
HGNC
NCBI Gene ID
2592
NCBI Gene
HGNC ID
HGNC:4135
HGNC
Ensembl
ENSG00000213930
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P07902Galactose-1-phosphate uridylyltransferase3792Ensembl, GeneID, HGNC

Source UniProt

Patents46

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-21124P07902Espacenet
JP 2025169942 A2025-11-14995P07902Espacenet
EP 4641201 A22025-10-2910387P07902Espacenet
JP 2025517969 A2025-06-1210387P07902Espacenet
EP 4555087 A22025-05-2164P07902Espacenet
US 12252704 B22025-03-181P07902Espacenet
JP 2025004107 A2025-01-144P07902Espacenet
JP 2024534905 A2024-09-261P07902Espacenet
EP 4395808 A12024-07-101P07902Espacenet
EP 4396360 A22024-07-101P07902Espacenet

1 to 10 of 46

See all 46 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,026

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleGALT papersNewest fiscal year
P01AI045897A Tolerance Approach to Xenotransplantation402025
P30AI027763UCSF-Bay Area Center for AIDS Research42025
R01GM083144Characterization of mammalian COG complex-interacting Golgi trafficking machinery42025
R01GM125939Chemical Tools for the Investigation and Manipulation of Protein Glycosylation42025
P30CA008748Cancer Center Support Grant32025
P30DK048520Colorado Nutrition Obesity Research Center32025
R01DA012864Mechanisms and Cellular Function of Opioid Receptor Endocytosis32025
UL1TR001863Yale Clinical and Translational Science Award32025
K12HD000849Reproductive Scientist Development Program22025
P30AI045008Penn Center for AIDS Research22025

1 to 10 of 1,026Source NIH's project files

See all 1,026 nih grants

Papers1,787

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Development and internal validation of a six-gene prognostic model based on galactose metabolism for overall survival in lung adenocarcinoma.Transl Cancer Res202642724461PubTator, text miningPubMed
Not all sugars are equal: galactose interference leading to false hyperglycaemia in a case of classical galactosaemia.J Pediatr Endocrinol Metab202642717884PubTator, text miningPubMed
Preparation and application of lacto-N-biose synthases immobilized onto amino-modified SiO2 nanoparticles.Int J Biol Macromol202642667945PubTator, text miningPubMed
Exploring Targets for Heart Failure Using Mendelian Randomization, Colocalization, Summary Data-based Mendelian Randomization, and Drug Prediction.J Vis Exp202642507612PubTator, text miningPubMed
Reproductive potential in classical galactosemia: A case series based perspective.Eur J Obstet Gynecol Reprod Biol X202642383232PubTator, text miningPubMed
Early proteomic and metabolomic signatures in diabetes associated with progression to diabetic retinopathy over 1-2 years.Front Endocrinol (Lausanne)202642358678PubTator, text miningPubMed
Diagnostic efficiency of whole exome sequencing in the search for genetic causes of hereditary diseases in Yugra (West Siberia, Russia).Vavilovskii Zhurnal Genet Selektsii202642253454PubTator, text miningPubMed
Transcriptomic profiling of the ovarian immune landscape reveals distinct macrophage subsets and activation of the NLRP3 inflammasome likely contributing to accelerated follicular atresia in classic galactosemia.
Cell Commun Signal202642226209PubTator, text miningPubMed
Optimising newborn screening for galactosaemia: reclassifying GALE and GALM deficiencies as non-target conditions to improve specificity.Clin Chem Lab Med202642126257PubTator, text miningPubMed
Heritability of Long-Term Complications in Classic Galactosemia.J Inherit Metab Dis202641905783PubTator, text miningPubMed

1 to 10 of 1,787

See all 1,787 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2592

GET https://conductscience.org/api/genes/v1/2592/patents?page=2